发表研究结果有使用 ab19027?请让我们知道,以便我们可以引用本数据表中的参考文章。

ab19027 被引用在 21 文献中.

  • Manku G & Culty M Regulation of Translocator Protein 18 kDa (TSPO) Expression in Rat and Human Male Germ Cells. Int J Mol Sci 17:N/A (2016). PubMed: 27608010
  • Katsuyama E  et al. Interleukin-1 receptor-associated kinase-4 (IRAK4) promotes inflammatory osteolysis by activating osteoclasts and inhibiting formation of foreign body giant cells. J Biol Chem 290:716-26 (2015). IHC-P ; Mouse . PubMed: 25404736
  • Ju X  et al. Neuraminidase of Influenza A Virus Binds Lysosome-Associated Membrane Proteins Directly and Induces Lysosome Rupture. J Virol 89:10347-58 (2015). PubMed: 26246576
  • Liang N  et al. Regulation of YAP by mTOR and autophagy reveals a therapeutic target of tuberous sclerosis complex. J Exp Med 211:2249-63 (2014). IHC-P ; Mouse . PubMed: 25288394
  • Murphy KE  et al. Reduced glucocerebrosidase is associated with increased a-synuclein in sporadic Parkinson's disease. Brain 137:834-48 (2014). PubMed: 24477431
  • Huyard F  et al. Remodeling of aorta extracellular matrix as a result of transient high oxygen exposure in newborn rats: implication for arterial rigidity and hypertension risk. PLoS One 9:e92287 (2014). IF ; Rat . PubMed: 24743169
  • Maekawa T  et al. Genetic and intervention studies implicating complement C3 as a major target for the treatment of periodontitis. J Immunol 192:6020-7 (2014). PubMed: 24808362
  • Xu Q  et al. Ultraviolet A-induced cathepsin K expression is mediated via MAPK/AP-1 pathway in human dermal fibroblasts. PLoS One 9:e102732 (2014). WB ; Human . PubMed: 25048708
  • Boeyens JC  et al. Effects of ?3- and ?6-polyunsaturated fatty acids on RANKL-induced osteoclast differentiation of RAW264.7 cells: a comparative in vitro study. Nutrients 6:2584-601 (2014). WB . PubMed: 25010555
  • Hassanpour S  et al. The actin binding protein adseverin regulates osteoclastogenesis. PLoS One 9:e109078 (2014). WB ; Mouse . PubMed: 25275604
  • Verbovšek U  et al. Expression analysis of all protease genes reveals cathepsin K to be overexpressed in glioblastoma. PLoS One 9:e111819 (2014). IHC-Fr, WB ; Human . PubMed: 25356585
  • Charli-Joseph Y  et al. Primary cutaneous perivascular epithelioid cell tumor: a clinicopathological and molecular reappraisal. J Am Acad Dermatol 71:1127-36 (2014). PubMed: 25267378
  • Grevers LC  et al. Immune complex-induced inhibition of osteoclastogenesis is mediated via activating but not inhibitory Fc? receptors on myeloid precursor cells. Ann Rheum Dis 72:278-85 (2013). Mouse . PubMed: 22918932
  • Lin YY  et al. A soft coral-derived compound, 11-epi-sinulariolide acetate suppresses inflammatory response and bone destruction in adjuvant-induced arthritis. PLoS One 8:e62926 (2013). IHC-P ; Rat . PubMed: 23675440
  • Rementer CW  et al. An inducible, ligand-independent receptor activator of NF-?B gene to control osteoclast differentiation from monocytic precursors. PLoS One 8:e84465 (2013). PubMed: 24386387
  • Petrey AC  et al. Excessive activity of cathepsin K is associated with cartilage defects in a zebrafish model of mucolipidosis II. Dis Model Mech 5:177-90 (2012). IHC-P ; Zebrafish . PubMed: 22046029
  • Schmit JM  et al. Cathepsin K expression and activity in canine osteosarcoma. J Vet Intern Med 26:126-34 (2012). WB, ICC/IF ; Human, Dog . PubMed: 22171552
  • Voigt M  et al. Fibroblast growth factor (FGF)-23 and fetuin-A in calcified carotid atheroma. Histopathology 56:775-88 (2010). IHC-P ; Human . PubMed: 20546343
  • Dominici M  et al. Restoration and reversible expansion of the osteoblastic hematopoietic stem cell niche after marrow radioablation. Blood 114:2333-43 (2009). IHC-P ; Mouse . PubMed: 19433859
  • Quintanilla-Dieck MJ  et al. Expression and regulation of cathepsin K in skin fibroblasts. Exp Dermatol 18:596-602 (2009). WB ; Human . PubMed: 19469903
  • Quintanilla-Dieck MJ  et al. Cathepsin K in melanoma invasion. J Invest Dermatol 128:2281-8 (2008). WB ; Human . PubMed: 18368130

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"